Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 1015-1022

  Takano, Yoshiko ^a   Ohguro, Hiroshi ^a   Dezawa, Mari ^b   Ishikawa, Hiroto ^b   Yamazaki, Hitoshi ^a   Ohguro, Ikuyo ^a   Mamiya, Kazuhisa ^a   Metoki, Tomomi ^a   Ishikawa, Futoshi ^a   Nakazawa, Mitsuru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DILTIAZEM; NICARDIPINE; NIFEDIPINE; NILVADIPINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM METABOLISM; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG EFFICACY; FUNCTIONAL MORPHOLOGY; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTOREACTIVITY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA DEGENERATION; STATISTICAL SIGNIFICANCE;

EID: 9144222598     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.034     Document Type: Article

References (46)

1. Soeft S.V., Westerveld A., Dejong P.T.V.M., Bleeker-Wagemkers E.M., Bergen A.A.B. Retinitis pigmentosa: defined from a molecular point of view. Surv. Ophthalmol. 43:1999;321-334.
2. Bowes C., Li T., Danciger M., Baxter L.C., Farber D.B. Retinal degeneration in rd mouse is caused by a defect in the b-subunit of rod cGMP-phosphodiesterase. Nature. 347:1999;677-680.
3. McLaughlin M.E., Sandberg M.A., Berson E.L., Dryja T.P. Recessive mutations in the gene encoding the b-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat. Genet. 4:1993;130-133.
4. Frasson M., Sahel J.A., Fabre M., Simonutti M., Dreyfus H., Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat. Med. 5:1999;1183-1187.
5. Pawlyk B.S., Li T., Scimeca M.S., Sandberg M.A., Berson E.L. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest. Ophthalmol. Vis. Sci. 43:2002;1912-1915.
6. Peace K.S.E., Aleman T.S., Nickle A., Laties A.M., Aquirre G.D., Jacobson S.G., Acland G.M. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa. Mol. Vis. 7:2001;42-47.
7. Bush R.A., Kononen L., Machid S., Sieving P.A. The effect of calcium blocker D-cis-diltiazem on photoreceptor degeneration in the rhodopsin Pro23His rat. Invest. Ophthalmol. Vis. Sci. 41:2000;2697-2701.
8. D'Cruz P.M., Yasumura D., Weir J., Matthes M.T., Abderrahim H., Lavail M.M., Vollrath D. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum. Mol. Genet. 9:2000;645-651.
9. 2+ antagonist, effectively preserves retinal morphology and functions in Royal College Surgeons rat. Invest. Ophthalmol. Vis. Sci. 43:2002;919-926.
10. 2+ antagonist administration and dark adaptation. Invest. Ophthalmol. Vis. Sci. 42:2001;2589-2595.
11. Hof R.P. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and D-cis-diltiazem. Br. J. Pharmacol. 78:1983;375-394.
12. Ohtsuka M., Yokota M., Kodama I., Yamada K., Shibata S. New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen. Pharmacol. 20:1989;539-556.
13. Kuramoto K. Double-blind studies of calcium antagonists in the treatment of hypertension in Japan. J. Cardiovasc. Pharmacol. 13:1989;S29-S35.
14. Machida S., Kondo M., Jamison J.A., Khan N.W., Kononen L.T., Sugawara T., Bush R.A., Sieving P.A. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest. Ophthalmol. Vis. Sci. 41:2000;3200-3209.
15. Troy C.M., Salvesen G.S. Caspases on the brain. J. Neurosci. 69:2002;145-150.
16. Soejima H., Miyoshi O., Yoshinaga H., Masaki Z., Ozaki I., Kajiwara S., Niikawa N., Matsuhashi S., Mukai T. Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet. Cell Genet. 87:1999;113-114.
17. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66:2002;407-425.
18. 2+ signaling. J. Neurochem. 76:2001;321-331.
19. Schafer U., Seibold S., Scneider A., Neugebauer E. Isolation and characterization to the human rab18 gene after stimulation of endothelial cells with histamine. FEBS Lett. 466:2000;148-154.
20. East L., Isacke C.M. The mannose receptor family. Biochim. Biophys. Acta. 1572:2002;364-386.
21. Crosas B., Cederlund E., Torres D., Jornvall H., Farres J., Pares X. A vertebrate aldo-keto reductase active with retinoids and ethanol. J. Biol. Chem. 276:2001;19132-19140.
22. Aldrich M.B., Blackburn M.R., Kellems R.E. The importance of adenosine deaminase for lymphocyte development and function. Biochem. Biophys. Res. Commun. 272:2000;311-315.
23. Akerstom B., Logdberg L., Berggard T., Osmark P., Lindqvist A. α1-Microglobulin: a yellow-brown lipocalin. Biochim. Biochem. Acta. 1482:2000;172-184.
24. Ethell I.M., Hagihara K., Miura Y., Irie F., Yamaguchi Y. Syndecan, a novel syndecan 2 binding protein in neural dendritic spines. J. Cell Biol. 151:2000;53-68.
25. Gundluch A.L., Burazin T.C., Larm J.A., Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family Clin. Exp. Pharmacol. Physiol. 281:2001;100-105.
26. MacEwan D.J. TNF receptor subtype signaling: difference and cellular consequences. Cell. Signal. 14:2002;477-492.
27. Morgan K.G., Gangopadhyay S.S. Cross-bridge regulation by thin filament-associated proteins. J. Appl. Physiol. 91:2001;953-962.
28. Dizhoor A.M. Regulation of cGMP synthesis in photoreceptors: role in signal transduction and congenital diseases of the retina. Cell. Signal. 12:2000;711-719.
29. Liu Y., Steinacker J.M. Changes in skeletal muscle heat shock proteins: pathological significance. Front Biosci. 6:2001;12-25.
30. - channels in the rat retina. Prog. Retin. Eye Res. 17:1998;99-126.
31. Stryer L. The molecules of visual excitation. Sci. Am. 257:1987;42-50.
32. Stork P.J.S., Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;258-266.
33. Janz R., Sudhof T.C., Hammer R.E., Unni V., Siegelbaum S.A., Bolshakov V.Y. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron. 24:1999;687-700.
34. Faktorovich E.G., Steinberg R.H., Yasumura D., Matthes M.T., LaVail M.M. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature. 347:1990;83-86.
35. Faktorovich E.G., Steinberg R.H., Yasumura D., Matthes M.T., Lavail M.M. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J. Neurosci. 12:1992;3554-3567.
36. LaVail M.M., Unoki K., Yasumura D., Matthes M.T., Yancopoulos G.D., Steinberg R.H. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. 89:1992;11249-11253.
37. Perry J., Du J., Kjeldbye H., Gouras P. The effects of bFGF on RCS rat eyes. Curr. Eye Res. 14:1995;585-592.
38. Gao H., Hollyfield J.G. Basic fibroblast growth factor: increased gene expression in inherited and light-induced photoreceptor degeneration. Exp. Eye Res. 62:1996;181-189.
39. Fontaine V., Kinkl N., Sahel J., Dreyfus H., Hicks D. Survival of purified rat photoreceptors in vitro is stimulated directly by fibroblast growth factor-2. J. Neurosci. 18:1998;9662-9672.
40. Lau D., McGee L.H., Zhou S., Rendahl K.G., Manning W.C., Escobedo J.A., Flannery J.G. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest. Ophthalmol. Vis. Sci. 41:2000;3622-3633.
41. Triggle D.H. Calcium antagonist: basic chemical and pharmacological aspects. Weiss G.B. New Perspectives on Calcium Antagonists. 1981;1-21 American Physilogical Society, Bethesda, MD.
42. Tokuma Y., Fujiwara T., Noguchi H. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica. 17:1987;1341-1349.
43. 2+ channels in rat hippocampal CA1 pyramidal neurons. Brain Res. 813:1998;121-127.
44. Sato M., Ohguro H., Ohguro I., Mamiya K., Takano Y., Yamazaki H., Metoki T., Miyagawa Y., Ishikawa F., Nakazawa M. Study of pharmacological effects of nilvadipine on RCS rat retinal degeneration by microarray analysis. Biochem. Biophys. Res. Commun. 306:2003;826-831.
45. 2+-dependent exocytosis in PC12 cells. J. Biol. Chem. 274:1999;18893-18901.
46. Wagner J.A. Fibroblast growth factors: an emerging gamily of neuronal growth factors. Curr. Top. Microbiol. Immunol. 165:1991;95-118.